KRAS and neoplasm: In the remaining four out of six cases, no single gene variant overlapped within the simultaneous tumor genomes despite the relatively large series of positive events, including characteristic driver mutations (e.g., VHL, KRAS, PIK3CA, PTEN, and TP53).